Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
639.5 DKK | +3.56% | +9.04% | +71.36% |
Sales 2024 * | 441M 64.11M | Sales 2025 * | 1.02B 148M | Capitalization | 39.84B 5.79B |
---|---|---|---|---|---|
Net income 2024 * | -653M -94.97M | Net income 2025 * | -399M -58.03M | EV / Sales 2024 * | 85 x |
Net cash position 2024 * | 2.37B 345M | Net cash position 2025 * | 2.44B 355M | EV / Sales 2025 * | 36.7 x |
P/E ratio 2024 * |
-64
x | P/E ratio 2025 * |
-67.3
x | Employees | 270 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.28% |
Latest transcript on Zealand Pharma A/S
1 day | +3.56% | ||
1 week | +9.04% | ||
1 month | +1.03% | ||
3 months | -3.69% | ||
6 months | +90.33% | ||
Current year | +71.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 09-12-31 | |
Director of Finance/CFO | - | 22-10-31 | |
Ivan M. Møller
COO | Chief Operating Officer | 52 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leonard Kruimer
BRD | Director/Board Member | 66 | 19-04-03 |
Chairman | 69 | 14-12-31 | |
Kirsten Drejer
BRD | Director/Board Member | 68 | 18-04-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - | |
0.00% | 45 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 639.5 | +3.56% | 396,087 |
24-05-30 | 617.5 | +0.41% | 180,884 |
24-05-29 | 615 | +0.08% | 176,249 |
24-05-28 | 614.5 | -0.41% | 237,079 |
24-05-27 | 617 | +5.20% | 303,643 |
Delayed Quote Nasdaq Copenhagen, May 31, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.36% | 5.79B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ZEAL Stock